Paper36740986
The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer.
Hargadon KM and 1 other. Technol Cancer Res Treat, 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer. Papers, record 36740986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36740986
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance, Neoplasm | Major topic |
| Forkhead Transcription Factors | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Signal Transduction |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28323030 | Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. | Cancer Lett | 2017 | https://conductscience.org/library/papers/28323030 | PubMed |
| 2 | 35392966 | Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35392966 | PubMed |
| 3 | 28397828 | EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. | Nat Rev Clin Oncol | 2017 | https://conductscience.org/library/papers/28397828 | PubMed |
| 4 | 23378344 | FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. | Cancer Res | 2013 | https://conductscience.org/library/papers/23378344 | PubMed |
| 5 | 33869020 | The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis. | Front Oncol | 2021 | https://conductscience.org/library/papers/33869020 | PubMed |
| 6 | 32175283 | RNA-seq Analysis of Wild-Type vs. FOXC2-Deficient Melanoma Cells Reveals a Role for the FOXC2 Transcription Factor in the Regulation of Multiple Oncogenic Pathways. | Front Oncol | 2020 | https://conductscience.org/library/papers/32175283 | PubMed |
| 7 | 31367258 | Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein. | Theranostics | 2019 | https://conductscience.org/library/papers/31367258 | PubMed |
| 8 | 32170602 | Foxc2 Alleviates Ox-LDL-Induced Lipid Accumulation, Inflammation, and Apoptosis of Macrophage via Regulating the Expression of Angptl2. | Inflammation | 2020 | https://conductscience.org/library/papers/32170602 | PubMed |
| 9 | 21507500 | Forkhead transcription factors: key players in health and disease. | Trends Genet | 2011 | https://conductscience.org/library/papers/21507500 | PubMed |
| 10 | 26893778 | Downregulation of Foxc2 enhances apoptosis induced by 5-fluorouracil through activation of MAPK and AKT pathways in colorectal cancer. | Oncol Lett | 2016 | https://conductscience.org/library/papers/26893778 | PubMed |
| 11 | 29577543 | A Forkhead Box Protein C2 Inhibitor: Targeting Epithelial-Mesenchymal Transition and Cancer Metastasis. | Chembiochem | 2018 | https://conductscience.org/library/papers/29577543 | PubMed |
| 12 | 25453096 | Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25453096 | PubMed |
| 13 | 20460685 | p120-catenin is transcriptionally downregulated by FOXC2 in non-small cell lung cancer cells. | Mol Cancer Res | 2010 | https://conductscience.org/library/papers/20460685 | PubMed |
| 14 | 35701636 | Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective. | Cancer Metastasis Rev | 2022 | https://conductscience.org/library/papers/35701636 | PubMed |
| 15 | 17537911 | Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17537911 | PubMed |
| 16 | 31623173 | FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31623173 | PubMed |
| 17 | 31659103 | The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness. | Cancer Genomics Proteomics | 2019 | https://conductscience.org/library/papers/31659103 | PubMed |
| 18 | 35406487 | FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406487 | PubMed |
| 19 | 26087469 | Areca nut contributes to oral malignancy through facilitating the conversion of cancer stem cells. | Mol Carcinog | 2016 | https://conductscience.org/library/papers/26087469 | PubMed |
| 20 | 21734725 | Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. | Cell Death Dis | 2011 | https://conductscience.org/library/papers/21734725 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926261 | Generation of Functional Gene Knockout Melanoma Cell Lines by CRISPR-Cas9 Gene Editing. | Methods Mol Biol | 2027 | https://conductscience.org/library/papers/42926261 | PubMed |
| 42454125 | Out"FOX"ing cancer: the implications of FOXC2 as a putative predictive biomarker for cancer immunotherapy. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42454125 | PubMed |
| 41755884 | m5C: Novel Diagnostic and Drug Repurposing Targets for Nonalcoholic Steatohepatitis. | Int J Genomics | 2026 | https://conductscience.org/library/papers/41755884 | PubMed |
| 41524843 | Fisetin-loaded Nanoemulsion and Fecal Microbiome Extract Enhance In Vitro Inhibition of Non-Small Cell Lung Cancer Progression. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/41524843 | PubMed |
| 41291552 | Transcription factor FOXC2 regulates miR-145/ADAMTS5 axis to inhibit angiogenesis in hepatocellular carcinoma via circular RNA 0002898. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41291552 | PubMed |
| 40764669 | Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation. | Br J Cancer | 2025 | https://conductscience.org/library/papers/40764669 | PubMed |
| 40024963 | Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40024963 | PubMed |
| 39516331 | lncRNAs'p potential roles in the pathogenesis of cancer via interacting with signaling pathways; special focus on lncRNA-mediated signaling dysregulation in lung cancer. | Med Oncol | 2024 | https://conductscience.org/library/papers/39516331 | PubMed |
| 39473610 | Cancer and lymphatic marker FOXC2 drives wound healing and fibrotic tissue formation. | Front Physiol | 2024 | https://conductscience.org/library/papers/39473610 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36740986
GET https://conductscience.org/api/papers/v1/36740986/references?page=2